PTK2B (inhibitor: defactinib) [63] was upregulated in merlin-deficient schwannoma cells by Panobinostat and AURKA (inhibitor: alisertib) [64] was upregulated in merlin-deficient meningioma upon treatment with GSK2126458 and CUDC-907. Here, AURKA is linked to schwannoma.